LeMaitre Vascular Inc. (NSDQ:LMAT) says it will close a Laguna Hills, Calif. manufacturing facility the company picked up in last year’s $2.8 million buyout of Angiotech Pharmaceuticals Inc.’s (NSDQ:ANPI) Lifespan vascular graft business.
The Burlington, Mass.-based cardiac device maker is expected to complete the closure by the end of the third quarter and move production to its Massachusetts facility.